Translating OMICS & Real-World Evidence into Meaningful Insights for Target Discovery & Clinical Trial Design
Time: 8:00 am
day: Pre-Conference Workshop A
Details:
The integration of OMICS data and real-world evidence is transforming drug development. With the increasing volume of CKD data generated through OMICS technologies and real-world evidence studies, there is a critical need to translate this information into actionable insights.
This workshop will explore how to leverage OMICS findings to enhance our understanding of disease mechanisms and identify novel therapeutic targets. Participants will learn how to translate these insights into effective clinical trial strategies, improving patient stratification and driving better outcomes in CKD and beyond, all to equip attendees with the knowledge to navigate the complexities of data-driven drug development
This workshop will gather experts to discuss:
- Discuss the current landscape of OMICS data collection and its potential to inform the identification of novel therapeutic targets
- Explore methods to integrate OMICS data with pathophysiological understanding, enabling the identification of mechanisms driving kidney diseases and guiding the discovery of new treatment avenues
- Review how RWE can inform adaptive trial designs and patient stratification, using data from kidney precision medicine projects and successful case studies
- Analyze insights from RWE studies on the importance of early CKD detection and how this can transform patient care and improve treatment protocols
- Examine comparative studies of patient pathways across different countries, highlighting the significance of understanding patient experiences in clinical trial designs.